<ѻýҕl>Male Fertility Problems in the Family Linked to Cancer Riskѻýҕl> Low sperm levels were tied to specific cancers in family members Feb 22, 2024
<ѻýҕl>Elotuzumab Misses Mark Again as Frontline Treatment for Multiple Myelomaѻýҕl> No PFS benefit from adding the monoclonal antibody to standard therapy Feb 20, 2024
<ѻýҕl>For Kids With Sickle Cell Disease Prescribed Opioids, No Patterns of Misuse Emergedѻýҕl> Number of vaso-occlusive crises tied to days' supply Feb 19, 2024
<ѻýҕl>Rush to Publish? Medicare Drug Plan Lawsuit Quashed; Activity Curbs Cancer Painѻýҕl> News, features, and commentary about cancer-related issues Feb 16, 2024
<ѻýҕl>Oldest Patient 'Cured' of HIV Still in Remission 5 Years After Transplant for AMLѻýҕl> But it's unlikely stem cell transplants will ever be large-scale cure for HIV, says expert Feb 14, 2024
<ѻýҕl>FLT3 Inhibitor Highly Active in Newly Diagnosed Acute Myeloid Leukemiaѻýҕl> Complete response rate of 86%, median event-free survival approaching 4 years with crenolanib Feb 13, 2024
<ѻýҕl>No Relief From Drug Shortages; New Lymphedema Guideline; A 'Good' Patient No Moreѻýҕl> News, features, and commentary about cancer-related issues Feb 09, 2024
<ѻýҕl>Pulled Myeloma Drug May Have a Role in Treating the Disease After Allѻýҕl> Belantamab mafodotin boosts PFS by nearly 2 years when combined with bortezomib, dexamethasone Feb 07, 2024
<ѻýҕl>All-Oral Therapy Promising in Higher-Risk MDS, CMMLѻýҕl> In small trial, overall response rate was 95% Feb 05, 2024
<ѻýҕl>Camp Lejeune Water Contamination Tied to a Range of Cancers, CDC Study Saysѻýҕl> Health risks now more firmly established, but study falls short of being definitive Feb 01, 2024
<ѻýҕl>Most Immunocompromised Patients Clear Omicron Infectionsѻýҕl> B-cell malignancies, B-cell treatments associated with longer duration of infection Jan 30, 2024
<ѻýҕl>When a Revolutionary Cancer Treatment Causes Cancerѻýҕl> The potential benefits of CAR T-cell therapies still far outweigh the risks Jan 27, 2024
<ѻýҕl>CAR-T Investigation: FDA Leaders Detail Decision on Cancer Risk Warningѻýҕl> Post-treatment cases grow to 22 since products' initial approvals Jan 24, 2024
<ѻýҕl>FDA Calls for New Boxed Warning on All CAR-T Productsѻýҕl> Most serious warning would alert patients, providers on potential risk for secondary malignancies Jan 23, 2024
<ѻýҕl>Gene Therapy for Sickle Cell Disease Likely Cost-Effective if Under $2 Millionѻýҕl> Lifetime reduction in acute pain episodes should offset high upfront costs of the therapy Jan 22, 2024
<ѻýҕl>Two Million Cancers; Casgevy OK'd for Thalassemia; Rectal Exams and Prostate Cancerѻýҕl> News, features, and commentary about cancer-related issues Jan 19, 2024
<ѻýҕl>Kate Middleton Hospitalized; Sen. Paul Urges Prison for Fauci; COVID Back in Classѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Jan 17, 2024
<ѻýҕl>Carvedilol No Help in Preventing Heart Failure in Childhood Cancer Survivorsѻýҕl> While safe, the results do not support use of the drug in anthracycline-exposed survivors Jan 10, 2024
<ѻýҕl>Direct Thrombin Inhibitor Shows Benefit for Progressing Strokeѻýҕl> Urgent anticoagulation with argatroban shows no bleeding downside in EASE trial Jan 09, 2024
<ѻýҕl>Gene Therapy for Hemophilia Becomes a Realityѻýҕl> Uptake of new options for hemophilia A and B has been a bit slow Dec 29, 2023
<ѻýҕl>Chemo-Free Quadruplet Promising as Initial Treatment in DLBCLѻýҕl> Approach could allow for a response-adapted reduction of CHOP Dec 27, 2023 video
<ѻýҕl>Longer Letermovir Prophylaxis Reduced Risk of Cytomegalovirus Infection After HSCTѻýҕl> Randomized study showed extending prophylaxis from 100 to 200 days was effective and safe Dec 27, 2023
<ѻýҕl>Tisa-Cel Yields Durable Responses in R/R Follicular Lymphomaѻýҕl> Our panel of experts discuss 3-year findings from the phase II ELARA study Dec 26, 2023 video
<ѻýҕl>Mammo Responsibility Ups Screening; Opioids for Cancer Pain? Ignored Signs of CRCѻýҕl> News, features, and commentary about cancer-related issues Dec 21, 2023
<ѻýҕl>JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphomaѻýҕl> Phase II findings on golidocitinib will form the basis of an accelerated approval application Dec 15, 2023
<ѻýҕl>Hematocrit Stabilized in Polycythemia Vera Treated With Novel Hepcidin Mimeticѻýҕl> Rusfertide maintained hematocrit Dec 15, 2023
<ѻýҕl>Ibrutinib-Venetoclax Improves PFS in R/R Mantle Cell Lymphomaѻýҕl> Will results revive ibrutinib role in MCL following withdrawal of accelerated approval? Dec 13, 2023
<ѻýҕl>'Half-Matched' BMTs Effective in Severe Sickle Cell Diseaseѻýҕl> High survival rates observed in patients not normally suitable for transplant Dec 13, 2023
<ѻýҕl>Pomalidomide Cuts Severe Epistaxis in Genetic Bleeding Disorderѻýҕl> 24 weeks of daily treatment significantly reduced recurrent nosebleeds in HHT trial Dec 13, 2023
<ѻýҕl>Four Drugs Top Three for Upfront Treatment of Multiple Myelomaѻýҕl> Adding anti-CD38 antibodies boosts response and PFS, but timing, sequencing, cost questioned Dec 13, 2023
<ѻýҕl>Menin Inhibitor Yields 63% ORR in Heavily Pretreated Acute Leukemiaѻýҕl> Investigational drug revumenib now under review at FDA for KMT2A-rearranged disease Dec 12, 2023
<ѻýҕl>Ruxolitinib Combinations Reduce Spleen Volume in Myelofibrosisѻýҕl> Combos with navitoclax or pelabresib led to more patients achieving reductions Dec 12, 2023
<ѻýҕl>Axatilimab Shows Efficacy in Recurrent/Refractory GVHDѻýҕl> Highest overall response rate and least toxicity seen with lowest dose Dec 11, 2023
<ѻýҕl>MRD Tied to Allo-Transplant Benefit in NPM1-Mutated Acute Myeloid Leukemiaѻýҕl> No advantage for MRD-negative patients in first remission after induction, regardless of FLT3 ITD Dec 11, 2023
<ѻýҕl>A Closer Look at the Approval of CRISPR/Cas9 Gene Therapy for Sickle Cell Diseaseѻýҕl> This landmark event brings up broader considerations and implications for other diseases Dec 11, 2023
<ѻýҕl>ASCT Tops CAR T-Cell Therapy for Relapsed LBCL in Complete Remissionѻýҕl> Better 2-year PFS, OS, but not applicable to primary refractory disease Dec 10, 2023
<ѻýҕl>Lovo-Cel 'Life-Changing, Transformative' in Sickle Cell Diseaseѻýҕl> Near complete resolution of pain events in patients, including adolescents Dec 10, 2023
<ѻýҕl>AI and Breast Cancer Screening; Cancer After Treatment for Sickle Cellѻýҕl> Also in TTHealthWatch: mail-in cervical cancer screening kits Dec 09, 2023 podcast
<ѻýҕl>Milestone Gene Therapies for Sickle Cell Disease Greenlit by FDAѻýҕl> Casgevy and Lyfgenia approved for one-time treatment of sickle cell disease Dec 08, 2023
<ѻýҕl>Doing More With Less Bloodѻýҕl> Blood management programs can save money and resources Dec 07, 2023